Evaluation of psychological stress in confined environments using salivary, skin, and facial image parameters.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : Nature Publishing Group, copyright 2011-
    • Subject Terms:
    • Abstract:
      Detecting the influence of psychological stress is particularly important in prolonged space missions. In this study, we determined potential markers of psychological stress in a confined environment. We examined 23 Japanese subjects staying for 2 weeks in a confined facility at Tsukuba Space Center, measuring salivary, skin, and facial image parameters. Saliva was collected at four points in a single day to detect diurnal variation. Increases in salivary cortisol were detected after waking up on the 4th and 11th days, and at 15:30 on the 1st and in the second half of the stay. Transepidermal water loss (TEWL) and sebum content of the skin were higher compared with outside the facility on the 4th and 1st days respectively. Increased IL-1β in the stripped stratum corneum was observed on the 14th day, and 7 days after leaving. Differences in facial expression symmetry at the time of facial expression changes were observed on 11th and 14th days. Thus, we detected a transition of psychological stress using salivary cortisol profiles and skin physiological parameters. The results also suggested that IL-1β in the stripped stratum corneum and facial expression symmetry are possible novel markers for conveniently detecting psychological stress.
    • References:
      Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2635-40. (PMID: 23297197)
      Aviat Space Environ Med. 2004 Jul;75(7 Suppl):C28-35. (PMID: 15267073)
      J Physiol. 2010 Sep 15;588(Pt 18):3567-92. (PMID: 20660569)
      Arch Dermatol. 2001 Jan;137(1):53-9. (PMID: 11176661)
      Aerosp Med Hum Perform. 2016;87(11):912-920. (PMID: 27779949)
      Skin Pharmacol Physiol. 2008;21(5):283-92. (PMID: 18663342)
      J Invest Dermatol. 2001 Aug;117(2):309-17. (PMID: 11511309)
      PLoS One. 2015 Aug 07;10(8):e0134814. (PMID: 26252656)
      Psychoneuroendocrinology. 2009 Feb;34(2):163-71. (PMID: 19095358)
      Space Technol. 2002;22(3-4):137-44. (PMID: 12807141)
      Inflamm Allergy Drug Targets. 2014;13(3):177-90. (PMID: 24853682)
      Skin Res Technol. 2003 Feb;9(1):34-8. (PMID: 12535282)
      Brain Behav Immun. 2014 Aug;40:203-10. (PMID: 24704568)
      Brain Behav Immun. 2015 Nov;50:52-57. (PMID: 26116982)
      Int J Psychophysiol. 2011 Mar;79(3):378-84. (PMID: 21185884)
      Aviat Space Environ Med. 2013 Aug;84(8):867-71. (PMID: 23926666)
      Stress. 2013 Sep;16(5):483-92. (PMID: 23805796)
      Sci Rep. 2015 Aug 26;5:13367. (PMID: 26306804)
      Psychoneuroendocrinology. 2009 Jan;34(1):2-18. (PMID: 19041187)
      Clin Chim Acta. 2013 Oct 21;425:196-201. (PMID: 23939251)
      Br J Dermatol. 2001 Nov;145(5):716-9. (PMID: 11736894)
      Nat Rev Endocrinol. 2009 Jul;5(7):374-81. (PMID: 19488073)
      J Hum Evol. 2014 Sep;74:123-129. (PMID: 24742879)
      PLoS One. 2014 Mar 27;9(3):e93298. (PMID: 24675720)
      Psychoneuroendocrinology. 2013 Jan;38(1):50-7. (PMID: 22641005)
      J Dermatol Sci. 2010 Feb;57(2):95-101. (PMID: 20089382)
      Psychoneuroendocrinology. 2003 Oct;28(7):916-31. (PMID: 12892658)
      J Bone Miner Res. 2004 Nov;19(11):1771-8. (PMID: 15476576)
      Aerosp Med Hum Perform. 2016 Sep;87(9):781-9. (PMID: 27634697)
      World J Cardiol. 2015 Dec 26;7(12):882-8. (PMID: 26730293)
      Curr Mol Med. 2011 Jul;11(5):350-64. (PMID: 21568935)
      Acta Derm Venereol. 2007;87(2):135-9. (PMID: 17340019)
      Arch Dermatol. 2003 Jul;139(7):897-900. (PMID: 12873885)
      PLoS One. 2014 Apr 02;9(4):e87087. (PMID: 24695321)
      Horm Metab Res. 2007 Feb;39(2):85-95. (PMID: 17326004)
      Eur J Appl Physiol. 2004 May;91(5-6):508-15. (PMID: 14722779)
      Stress. 2014 Mar;17(2):149-56. (PMID: 24351081)
      Aerosp Med Hum Perform. 2015 Feb;86(2):131-5. (PMID: 25946738)
      Brain. 2013 Mar;136(Pt 3):815-27. (PMID: 23436504)
      Am J Crit Care. 2013 Sep;22(5):412-22. (PMID: 23996421)
      Osteoporos Int. 2013 Jul;24(7):2105-14. (PMID: 23334732)
      Aviat Space Environ Med. 2004 Jul;75(7 Suppl):C44-51. (PMID: 15267075)
      Psychol Sci. 2015 Jun;26(6):684-700. (PMID: 25870406)
    • Accession Number:
      0 (Biomarkers)
      0 (Interleukin-1beta)
      WI4X0X7BPJ (Hydrocortisone)
    • Publication Date:
      Date Created: 20180531 Date Completed: 20191125 Latest Revision: 20191125
    • Publication Date:
      20240628
    • Accession Number:
      PMC5974367
    • Accession Number:
      10.1038/s41598-018-26654-4
    • Accession Number:
      29844534